News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI Todd Neale October 29, 2024
News Conference News EACTS 2024 At EACTS 2024, Surgeons and Cardiologists Move Past EXCEL Firestorm Yael L. Maxwell October 22, 2024
News Conference News ESC 2024 REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD Todd Neale September 09, 2024
News Conference News ESC 2024 ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS Michael O'Riordan September 09, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Daily News Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years Yael L. Maxwell July 22, 2024
News Daily News RECOVER IV Impella Trial Halted in the Wake of DanGer Shock Caitlin E. Cox June 18, 2024
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Conference News SCAI 2024 Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs L.A. McKeown May 10, 2024
News Conference News ACC 2024 Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock Caitlin E. Cox April 07, 2024
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI L.A. McKeown February 06, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024